AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment ; volume:12 ; number:1 ; day:31 ; month:7 ; year:2014 ; pages:1-9 ; date:12.2014
Journal of translational medicine ; 12, Heft 1 (31.7.2014), 1-9, 12.2014
- Urheber
-
Caputo, Emilia
- Beteiligte Personen und Organisationen
-
Miceli, Roberta
Motti, Maria Letizia
Taté, Rosarita
Fratangelo, Federica
Botti, Gerardo
Mozzillo, Nicola
Carriero, Maria Vincenza
Cavalcanti, Ernesta
Palmieri, Giuseppe
Ciliberto, Gennaro
Pirozzi, Giuseppe
Ascierto, Paolo Antonio
SpringerLink (Online service)
- DOI
-
10.1186/s12967-014-0216-z
- URN
-
urn:nbn:de:1111-2016041450774
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Caputo, Emilia
- Miceli, Roberta
- Motti, Maria Letizia
- Taté, Rosarita
- Fratangelo, Federica
- Botti, Gerardo
- Mozzillo, Nicola
- Carriero, Maria Vincenza
- Cavalcanti, Ernesta
- Palmieri, Giuseppe
- Ciliberto, Gennaro
- Pirozzi, Giuseppe
- Ascierto, Paolo Antonio
- SpringerLink (Online service)
Ähnliche Objekte (12)
AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment
Zielgerichtete Kombinationstherapie von BRAF- und MEK-Inhibitor resistenten Melanomzellen
BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer
B-Raf and the inhibitors: from bench to bedside
Influence of BRAF-/MEK-inhibitors on the immunogenicity of melanoma cells
RIP1 protects melanoma cells from apoptosis induced by BRAF/MEK inhibitors
Combination therapy for melanoma with BRAF/MEK inhibitor and immune checkpoint inhibitor: a mathematical model
BRAF and MEK Inhibitors Affect Dendritic-Cell Maturation and T-Cell Stimulation
Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma
BRAF and MEK Inhibitor Treatment for Metastatic Undifferentiated Sarcoma of the Spermatic Cord with BRAF V600E Mutation
Optogenetically controlled RAF to characterize BRAF and CRAF protein kinase inhibitors
Efficacy of PARP inhibitor therapy after targeted BRAF/MEK failure in advanced melanoma
AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment
Zielgerichtete Kombinationstherapie von BRAF- und MEK-Inhibitor resistenten Melanomzellen
BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer
B-Raf and the inhibitors: from bench to bedside
Influence of BRAF-/MEK-inhibitors on the immunogenicity of melanoma cells
RIP1 protects melanoma cells from apoptosis induced by BRAF/MEK inhibitors
Combination therapy for melanoma with BRAF/MEK inhibitor and immune checkpoint inhibitor: a mathematical model
BRAF and MEK Inhibitors Affect Dendritic-Cell Maturation and T-Cell Stimulation
Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma
BRAF and MEK Inhibitor Treatment for Metastatic Undifferentiated Sarcoma of the Spermatic Cord with BRAF V600E Mutation
Optogenetically controlled RAF to characterize BRAF and CRAF protein kinase inhibitors
Efficacy of PARP inhibitor therapy after targeted BRAF/MEK failure in advanced melanoma
AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment
Zielgerichtete Kombinationstherapie von BRAF- und MEK-Inhibitor resistenten Melanomzellen
BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer
B-Raf and the inhibitors: from bench to bedside
Influence of BRAF-/MEK-inhibitors on the immunogenicity of melanoma cells
RIP1 protects melanoma cells from apoptosis induced by BRAF/MEK inhibitors
Combination therapy for melanoma with BRAF/MEK inhibitor and immune checkpoint inhibitor: a mathematical model
BRAF and MEK Inhibitors Affect Dendritic-Cell Maturation and T-Cell Stimulation
Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma
BRAF and MEK Inhibitor Treatment for Metastatic Undifferentiated Sarcoma of the Spermatic Cord with BRAF V600E Mutation
Optogenetically controlled RAF to characterize BRAF and CRAF protein kinase inhibitors